NewcelX

NewcelX Current Ratio

The Current Ratio of NewcelX (NCEL) as of Oct 21, 2026 is 0.76. In the previous year, Current Ratio was 0.95 — a change of -20.26% (lower).

Current Ratio

0.76

YoY

-20.26%

Last updated:

Current Ratio of NewcelX is 2025 0.76 . Current Ratio of NewcelX was 2024 0.95 . It decreases by -20.26% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewcelX Stock analysis

What does NewcelX do? NewcelX AG, based in Zurich, Switzerland, operates in the Health Care sector with a focus on Pharmaceuticals. The company, listed on 29 January 2021, develops therapeutics for neurobehavioral and neurocognitive disorders. With a small team of two employees, it serves customers globally, concentrating on innovative treatments for neurological conditions. NewcelX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewcelX stock

Current Ratio of NewcelX is 0.76 in 2025.

Current Ratio of NewcelX changed from 0.95 to 0.76, representing a -20.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio NewcelX since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's NewcelX with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NewcelX

All Key Metrics — NewcelX